SCHEMBL5504084

SCHEMBL5504084

Nc1cccc(Nc2ncc(Br)cn2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 2/20 0.59
MEN1 O00255 2/20 0.52
LMNA P02545 2/20 0.52
GAA P10253 2/20 0.52
MAPT P10636 2/20 0.52
KMT2A Q03164 2/20 0.52
KDM4E B2RXH2 1/20 0.52
GFER P55789 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
BLK P51451 2/20 0.51
KDR P35968 1/20 0.50
EGFR P00533 4/20 0.49
ABL1 P00519 3/20 0.49
BCR P11274 2/20 0.49
SRC P12931 2/20 0.49
PRKACA P17612 1/20 0.49
PRKACG P22612 1/20 0.49
PRKACB P22694 1/20 0.49
IGF1R P08069 1/20 0.47
BTK Q06187 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24270328 0.86 SYK (0.62) SYKMEN1LMNAGAAMAPT
SCHEMBL6804201 0.82 ABL1 (0.60) SYKMEN1LMNAGAAMAPT
SCHEMBL13362987 0.79 MAP3K5 (0.62) SYKBLKKDREGFRABL1
SCHEMBL3949289 0.79 HDAC3 (0.64) SYKMEN1GAAMAPTKMT2A
SCHEMBL180866 0.79 KDR (0.54) SYKMEN1MAPTKMT2AKDM4E
SCHEMBL30091782 0.79 HDAC3 (0.64) SYKMEN1GAAMAPTKMT2A
SCHEMBL28104563 0.79 BTK (0.61) SYKMEN1LMNAGAAMAPT
SCHEMBL16588349 0.78 RAPGEF4 (0.50) SYKMEN1LMNAGAAMAPT
SCHEMBL31302305 0.77 MEN1 (0.63) SYKMEN1LMNAGAAMAPT
SCHEMBL11795454 0.77 MEN1 (0.63) SYKMEN1LMNAGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 US disclosed
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 US disclosed
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 US disclosed
EP-1753750-A1 THIOPHENE HETEROARYL AMINES Sugen, Inc. (US) 2007-02-21 EP disclosed
WO-2005113548-A1 THIOPHENE HETEROARYL AMINES SUGEN, INC. (US) 2005-12-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293484-A1 Thiophene Heteroaryl Amines TTK, CHEK2, ABL1 SYK 720/4885MEN1 3002/4885LMNA 3969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.